{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:09:21Z","timestamp":1789056561089,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.rmed.2026.109083","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:07:37Z","timestamp":1785884857000},"page":"109083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Viewpoint: Pathway-sensitive eligibility for biologic therapy in COPD: The role of primary care, phenotyping, and eosinophil-guided management"],"prefix":"10.1016","volume":"262","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9657-3705","authenticated-orcid":false,"given":"Konstantinos","family":"Bartziokas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9431-4357","authenticated-orcid":false,"given":"Constantinos","family":"Glynos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9708-3241","authenticated-orcid":false,"given":"Andriana I.","family":"Papaioannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.rmed.2026.109083_bib2","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.chest.2024.09.049","article-title":"The emerging role of alarmin-targeting biologics in the treatment of patients with COPD","volume":"167","author":"Celli","year":"2025","journal-title":"Chest"},{"issue":"10098","key":"10.1016\/j.rmed.2026.109083_bib3","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S0140-6736(17)32136-0","article-title":"What does endotyping mean for treatment in chronic obstructive pulmonary disease?","volume":"390","author":"Agust\u00ed","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.rmed.2026.109083_bib4","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00651-2019","article-title":"Airway inflammation in COPD: progress to precision medicine","volume":"54","author":"Brightling","year":"2019","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.rmed.2026.109083_bib5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12890-025-04063-4","article-title":"Stability of blood eosinophils during acute exacerbations in patients with chronic obstructive pulmonary disease","volume":"26","author":"Chen","year":"2025","journal-title":"BMC Pulm. Med."},{"issue":"1","key":"10.1016\/j.rmed.2026.109083_bib6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/2040622315609251","article-title":"Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease","volume":"7","author":"George","year":"2016","journal-title":"Ther. Adv. Chronic Dis."},{"issue":"10","key":"10.1016\/j.rmed.2026.109083_bib7","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1164\/rccm.201701-0009LE","article-title":"Stability of blood eosinophils in patients with chronic obstructive pulmonary disease and in control subjects, and the impact of sex, age, smoking, and baseline counts","volume":"195","author":"Oshagbemi","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.rmed.2026.109083_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12931-020-1279-4","article-title":"The stability of blood Eosinophils in chronic obstructive pulmonary disease","volume":"21","author":"Long","year":"2020","journal-title":"Respir. Res."},{"issue":"1","key":"10.1016\/j.rmed.2026.109083_bib9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s41030-024-00280-0","article-title":"\u0395osinophilic chronic obstructive pulmonary disease. What do we know So far?","volume":"11","author":"Bartziokas","year":"2025","journal-title":"Pulm Ther"},{"issue":"1","key":"10.1016\/j.rmed.2026.109083_bib10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1164\/rccm.202201-0209PP","article-title":"Blood eosinophils and chronic obstructive pulmonary disease: a global initiative for chronic obstructive lung disease science committee 2022 review","volume":"206","author":"Singh","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"24","key":"10.1016\/j.rmed.2026.109083_bib11","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1056\/NEJMoa2401304","article-title":"Dupilumab for COPD with blood eosinophil evidence of type 2 inflammation","volume":"390","author":"Bhatt","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.rmed.2026.109083_bib12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2303951","article-title":"Dupilumab for COPD with type 2 inflammation indicated by eosinophil counts","volume":"389","author":"Bhatt","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"17","key":"10.1016\/j.rmed.2026.109083_bib13","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1056\/NEJMoa1708208","article-title":"Mepolizumab for eosinophilic chronic obstructive pulmonary disease","volume":"377","author":"Pavord","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"17","key":"10.1016\/j.rmed.2026.109083_bib14","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1056\/NEJMoa2413181","article-title":"Mepolizumab to prevent exacerbations of COPD with an eosinophilic phenotype","volume":"392","author":"Sciurba","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2026.109083_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2026.108681","article-title":"Eligibility for biological treatments in COPD patients experiencing a severe COPD exacerbation","volume":"253","author":"Zaneli","year":"2026","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2026.109083_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejim.2026.107012","article-title":"How many blood eosinophil measurements are needed to identify COPD patients eligible for biologic therapy? A multi-source decision analysis simulation","author":"Mari","year":"2026","journal-title":"Eur. J. Intern. Med."},{"issue":"9","key":"10.1016\/j.rmed.2026.109083_bib17","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1164\/rccm.201804-0621CI","article-title":"Underdiagnosis and overdiagnosis of chronic obstructive pulmonary disease","volume":"198","author":"Diab","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.rmed.2026.109083_bib18","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1164\/rccm.200708-1290OC","article-title":"Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort","volume":"177","author":"Langsetmo","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.rmed.2026.109083_bib19","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1186\/s12913-022-08588-w","article-title":"Determining the influence of the primary and specialist network of care on patient and system outcomes among patients with a new diagnosis of chronic obstructive pulmonary disease (COPD)","volume":"22","author":"Tranmer","year":"2022","journal-title":"BMC Health Serv. Res."},{"key":"10.1016\/j.rmed.2026.109083_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2025.108345","article-title":"Adherence to the chronic obstructive pulmonary disease guidelines in primary care: the Greek COPD COCARE study","volume":"248","author":"Tsiligianni","year":"2025","journal-title":"Respir. Med."},{"issue":"5","key":"10.1016\/j.rmed.2026.109083_bib21","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1164\/rccm.202407-1287RL","article-title":"Blood eosinophil count stability in chronic obstructive pulmonary disease and the eosinophilic exacerbator phenotype","volume":"211","author":"Baraldi","year":"2025","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2026.109083_bib22","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.2147\/COPD.S398816","article-title":"Real-world treatment patterns and switching following moderate\/severe chronic obstructive pulmonary disease exacerbation in patients with commercial or medicare insurance in the United States","volume":"18","author":"Bogart","year":"2023","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.rmed.2026.109083_bib23","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2147\/COPD.S191946","article-title":"Inflammation and infections in unreported chronic obstructive pulmonary disease exacerbations","volume":"14","author":"Calderazzo","year":"2019","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126004518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126004518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:44:12Z","timestamp":1789055052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611126004518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":22,"alternative-id":["S0954611126004518"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2026.109083","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Viewpoint: Pathway-sensitive eligibility for biologic therapy in COPD: The role of primary care, phenotyping, and eosinophil-guided management","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2026.109083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109083"}}